User menu

The Value of Bmt in Aml Patients in 1st Remission - a Statisticians Viewpoint

Bibliographic reference Suciu, Stefan. The Value of Bmt in Aml Patients in 1st Remission - a Statisticians Viewpoint. In: Annals of Hematology, Vol. 62, no. 2-3, p. 41-44 (1991)
Permanent URL http://hdl.handle.net/2078.1/51152
  1. Hermans J, Suciu S, Stijnen Th, Aegerter P, Gorin NG, Gratwohl A, Hayat M, Stryckmans P, Zittoun R, Zwaan FE (1989) An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol 25: 545–550
  2. Suciu S, Hermans J, Aegerter P, Gorin N, Gratwohl A, Hayat M, Solbu G, Zittoun R, Zwaan FE (1990) Bone marrow transplantation versus chemotherapy for AML patients in first remission: updated results of the EBMT-EORTC retrospective analysis. Bone Marrow Transplantation 5 [Suppl 2]: 15
  3. Willemze R, Fibbe E, Kluin-Nelemans JC, Falkenburg JHF, Richel DJ, Peters WG, den Ottolander GJ, Brand A, Zwaan FE (1991) Post-remission treatment of adult acute myelogenous leukemia, bone marrow transplantation versus chemotherapy. Ann Hematol 62: 59–63
  4. Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. John Wiley, New York